We will improve the health and well being of people and animals through being a part of an independent, innovative, research and development driven company. Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here for our Global Vision.
Are you taking one of our medicines?
Remember, if you have any concerns; please do not stop taking it without first speaking to your doctor.
If you are taking or being prescribed a Boehringer Ingelheim medicine and experience any adverse events, you should immediately report these to your doctor, or to another healthcare professional (such as a nurse or carer).
Adverse events can also be reported via the Drug Safety team at Boehringer Ingelheim on 01344 741346 or email PV_local_UK_Ireland@boehringer-ingelheim.com. You can also contact the MHRA through its Yellow Card reporting system at www.mhra.gov.uk/yellowcard.
Learn more about Pharmaphorum and Boehringer Ingelheim's White paper
Facts about us
We are one of the top 20 leading pharmaceutical companies in the world.
In 2010, worldwide, we had sales of €12.6 billion; while spending 24% of net sales in our largest business segment Prescription Medicines on research and development.
Our key areas of interest are: respiratory disease, cardiovascular disease, HIV, Parkinson's disease, thromboembolic disease and cerebrovascular disease.